ADILW - ADIAL PHARMACEUTICALS, INC.
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-04-2025 | 05-14-2025 | 08-13-2025 | 11-13-2025 | 03-05-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 1.941 M | 2.267 M | 1.883 M | 1.764 M | 1.885 M | |
| Selling general and admin | 1.210 M | 1.520 M | 1.150 M | 1.243 M | 1.266 M | |
| Research and development | 730.793 K | 746.891 K | 732.315 K | 521.069 K | 619.396 K | |
| Total expenses | 1.941 M | 2.267 M | 1.883 M | 1.764 M | 1.885 M | |
| 16.83% | -16.96% | -6.30% | 6.88% | |||
| Operating income | -1.941 M | -2.267 M | -1.883 M | -1.764 M | -1.885 M | |
| Ebit | -2.016 M | -2.101 M | -1.884 M | -1.765 M | -1.885 M | |
| Pretax income | -2.071 M | -2.229 M | -1.959 M | -1.794 M | -1.996 M | |
| 7.63% | -12.13% | -8.42% | 11.29% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.071 M | -2.229 M | -1.959 M | -1.794 M | -1.996 M | |
| -7.63% | 12.13% | 8.42% | -11.29% |